Dawood Ghafoor

Mr. Dawood Ghafoor

Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Current Research in Toxicology
Verified
Journal Article
Open access
DGDawood Ghafoor
Dawood Ghafoor
ZKZafran Khan
Zafran Khan
AKAsaf Khan
Asaf Khan
DUDaniya Ualiyeva
Daniya Ualiyeva
NZNasib Zaman
Nasib Zaman
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan city of China in late December 2019 and identified as a novel coronavirus disease 2019 (COVID-19). On January 30, the World Health Organization (WHO) declared the coronavirus outbreak a global public health emergency. The rapid spread of the pathogen across the communities shock the entire population. As no existing therapy were available during the pandemic. Health professionals recommended frequent washing of hands with soap and alcohol-based sanitizers. Disinfectants were extensively sprayed to minimize the possibility of getting COVID-19. Despite the potential benefits of these germicidal agents against COVID-19. Alcohol-based hand sanitizers lead to dry skin, infection, and alcohol poisoning. Children are considered more prone to alcohol poisoning and other major health concern. Precautionary measures should be ensured to protect the community from the possible risk associated with disinfectants.

11 May 2021 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
ZKZafran Khan
Zafran Khan
DUDaniya Ualiyeva
Daniya Ualiyeva
AKAsaf Khan
Asaf Khan
NZNasib Zaman
Nasib Zaman
SSSanjeep Sapkota
Sanjeep Sapkota
DGDawood Ghafoor
Dawood Ghafoor
Air pollution (AP) is one of the leading causes of health risks because it causes widespread morbidity and mortality every year. Its impact on the environment includes acid rain and decreased visibility, but more importantly, it also has an impact on human health. The rise of COVID-19 demonstrates the cost of failing to manage AP. COVID-19 can be spread through the air, and atmospheric particulate matters (PMs) can create a good atmosphere for the long-distance spread of the virus. Moreover, these PMs can cause lung cell inflammation, thereby increasing sensitivity and the severity of symptoms in COVID-19 patients. In this study, we emphasized the potential role of PMs in the spread of COVID-19. The relationship among COVID-19, PMs, and angiotensin-converting enzyme 2 (ACE2) (receptor involved in virus entry into lung cells and inflammation) was also summarized.

1 November 2020 in New Microbes and New Infections
Verified
Journal Article
Open access
ZKZ. Khan
Z. Khan
DGDawood Ghafoor
Dawood Ghafoor
AKA. Khan
A. Khan
DUD. Ualiyeva
D. Ualiyeva
SKS.A. Khan
S.A. Khan
WSW. Sajjad
W. Sajjad
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan city of China in late December 2019 and identified as a novel coronavirus. Due to its contagious nature, the virus spreads rapidly and causes coronavirus disease 2019 (COVID-19). The global tally of COVID-19 was 28 million in early September 2020. The fears and stress associated with SARS-CoV-2 has demolished the socio-economic status worldwide. Researchers are trying to identify treatments, especially antiviral drugs and/or vaccines, that could potentially control the viral spread and manage the ongoing unprecedented global crisis. To date, more than 300 clinical trials have been conducted on various antiviral drugs, and immunomodulators are being evaluated at various stages of COVID-19. This review aims to collect and summarize a list of drugs used to treat COVID-19, including dexamethasone, chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, remdesivir, tociluzimab, nitazoxanide and ivermectin. However, some of these drugs are not effective and their use has been suspended by WHO.